IGF-1 and IGFBP-3 in Inflammatory Cachexia.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Aug 2021
Historique:
received: 10 07 2021
revised: 05 08 2021
accepted: 28 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 3 11 2021
Statut: epublish

Résumé

Inflammation induces a wide response of the neuroendocrine system, which leads to modifications in all the endocrine axes. The hypothalamic-growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis is deeply affected by inflammation, its response being characterized by GH resistance and a decrease in circulating levels of IGF-1. The endocrine and metabolic responses to inflammation allow the organism to survive. However, in chronic inflammatory conditions, the inhibition of the hypothalamic-GH-IGF-1 axis contributes to the catabolic process, with skeletal muscle atrophy and cachexia. Here, we review the changes in pituitary GH secretion, IGF-1, and IGF-1 binding protein-3 (IGFBP-3), as well as the mechanism that mediated those responses. The contribution of GH and IGF-1 to muscle wasting during inflammation has also been analyzed.

Identifiants

pubmed: 34502376
pii: ijms22179469
doi: 10.3390/ijms22179469
pmc: PMC8430490
pii:
doi:

Substances chimiques

IGF1 protein, human 0
IGFBP3 protein, human 0
Insulin 0
Insulin-Like Growth Factor Binding Protein 3 0
Human Growth Hormone 12629-01-5
Insulin-Like Growth Factor I 67763-96-6
Growth Hormone 9002-72-6

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Comunidad de Madrid, spain
ID : IND2017/BIO7701

Références

Endocrinology. 1997 Mar;138(3):1078-84
pubmed: 9048612
Arthritis Res Ther. 2014 Feb 13;16(1):203
pubmed: 24524669
Metabolism. 2018 Feb;79:10-23
pubmed: 29080813
Immunology. 1992 Nov;77(3):449-55
pubmed: 1478689
Int J Mol Sci. 2017 Sep 23;18(10):
pubmed: 28946616
Vitam Horm. 2006;74:317-40
pubmed: 17027521
J Clin Endocrinol Metab. 2007 Aug;92(8):3013-8
pubmed: 17535995
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7324-9
pubmed: 10377413
Am J Physiol Endocrinol Metab. 2014 Jul 15;307(2):E186-98
pubmed: 24895283
Growth Horm IGF Res. 2019 Oct - Dec;48-49:36-44
pubmed: 31494533
J Clin Endocrinol Metab. 1998 Jun;83(6):1827-34
pubmed: 9626104
Clin Lab. 2018 May 1;64(5):759-765
pubmed: 29739044
Regul Pept. 2005 Jan 15;124(1-3):113-8
pubmed: 15544848
Infect Immun. 2002 Jul;70(7):3433-42
pubmed: 12065483
Annu Rev Med. 2011;62:265-79
pubmed: 20731602
Exp Cell Res. 2005 Nov 15;311(1):167-76
pubmed: 16214131
J Endocrinol. 2003 Feb;176(2):227-35
pubmed: 12553871
Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E50-6
pubmed: 13129855
Mediators Inflamm. 2014;2014:179368
pubmed: 25294954
Front Cell Dev Biol. 2020 May 05;8:286
pubmed: 32478064
J Mol Endocrinol. 2018 Jul;61(1):T115-T137
pubmed: 29626053
Clin Nutr. 2016 Apr;35(2):408-413
pubmed: 25817945
Am J Physiol. 1982 Oct;243(4):E332-7
pubmed: 7124945
Metabolism. 2009 Jun;58(6):787-97
pubmed: 19375133
Adv Exp Med Biol. 2018;1088:207-233
pubmed: 30390253
PLoS One. 2016 May 13;11(5):e0155645
pubmed: 27177152
Crit Care Med. 2006 May;34(5):1420-7
pubmed: 16540952
J Endocrinol. 2005 Jun;185(3):467-76
pubmed: 15930173
J Endocrinol. 2006 Sep;190(3):847-56
pubmed: 17003285
Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E131-41
pubmed: 17986630
Crit Care Med. 2017 Sep;45(9):e971-e979
pubmed: 28538438
Crit Care Med. 2015 Dec;43(12):2651-9
pubmed: 26427594
Curr Drug Metab. 2004 Oct;5(5):399-413
pubmed: 15544434
Growth Horm IGF Res. 2008 Feb;18(1):17-25
pubmed: 17826224
Clin Endocrinol (Oxf). 1991 Jul;35(1):47-54
pubmed: 1909610
Endocr Rev. 2009 Aug;30(5):417-37
pubmed: 19477944
Mol Endocrinol. 2008 Jun;22(6):1427-37
pubmed: 18323468
J Endocrinol. 1993 Sep;138(3):545-54
pubmed: 7506292
Am J Clin Nutr. 2021 Feb 2;113(2):380-390
pubmed: 33381802
J Endocrinol. 2003 Oct;179(1):107-17
pubmed: 14529571
Mol Cell Endocrinol. 2003 Jan 31;199(1-2):23-8
pubmed: 12581876
J Exp Clin Cancer Res. 2016 Mar 15;35:46
pubmed: 26975989
BMC Gastroenterol. 2019 Jun 20;19(1):96
pubmed: 31221091
Front Endocrinol (Lausanne). 2020 Nov 18;11:597573
pubmed: 33312162
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1399-1412
pubmed: 32893974
J Clin Endocrinol Metab. 1994 Dec;79(6):1871-6
pubmed: 7527416
Pediatr Endocrinol Rev. 2015 Dec;13(2):499-511
pubmed: 26841638
J Clin Endocrinol Metab. 1998 Jul;83(7):2445-9
pubmed: 9661626
Cells. 2020 Jul 24;9(8):
pubmed: 32722232
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E705-E714
pubmed: 29969314
Toxicon. 2018 Jul;149:45-53
pubmed: 29056305
Life Sci. 1999;65(20):2049-60
pubmed: 10579459
Growth Horm IGF Res. 2012 Feb;22(1):22-9
pubmed: 22244673
Cells. 2020 Aug 26;9(9):
pubmed: 32858949
J Clin Endocrinol Metab. 2013 May;98(5):2090-9
pubmed: 23543661
Nutrition. 2017 Jan;33:248-253
pubmed: 27712965
Exp Ther Med. 2017 Jul;14(1):797-804
pubmed: 28673002
Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1133-43
pubmed: 10827017
J Clin Endocrinol Metab. 1993 Jun;76(6):1610-6
pubmed: 7684744
Immunol Rev. 2015 Jul;266(1):123-33
pubmed: 26085211
J Endocrinol. 2006 Mar;188(3):503-11
pubmed: 16522730
Am J Physiol Regul Integr Comp Physiol. 2010 Aug;299(2):R541-51
pubmed: 20519361
Endocrinology. 2006 May;147(5):2138-46
pubmed: 16455777
Cytokine Growth Factor Rev. 2018 Feb;39:1-18
pubmed: 29398400
Endocr Rev. 2016 Feb;37(1):62-110
pubmed: 26720129
Crit Care Med. 2011 Mar;39(3):456-61
pubmed: 21150583
Clin Nutr. 2016 Apr;35(2):322-330
pubmed: 25896101
Mutat Res Rev Mutat Res. 2020 Apr - Jun;784:108307
pubmed: 32430099
Mol Cell Endocrinol. 2009 Oct 15;309(1-2):8-16
pubmed: 19501629
Inflamm Bowel Dis. 2011 Nov;17(11):2318-25
pubmed: 21287667
Shock. 2019 Sep;52(3):353-361
pubmed: 30239418
Am J Physiol. 1997 Jul;273(1 Pt 2):R371-8
pubmed: 9249574
J Endocrinol. 2000 Jun;165(3):537-44
pubmed: 10828837
J Hepatol. 2001 Nov;35(5):558-67
pubmed: 11690700
Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E925-37
pubmed: 27245339
Growth Horm IGF Res. 2013 Aug;23(4):98-104
pubmed: 23611528
J Endocrinol. 1998 Nov;159(2):239-46
pubmed: 9795364
Front Endocrinol (Lausanne). 2018 Apr 09;9:117
pubmed: 29686648
Transplantation. 1995 Mar 15;59(5):755-61
pubmed: 7533956

Auteurs

Ana Isabel Martín (AI)

Department of Physiology, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.

Teresa Priego (T)

Department of Physiology, Faculty of Nursing, Physiotherapy and Podiatry, Complutense University of Madrid, 28040 Madrid, Spain.

Álvaro Moreno-Ruperez (Á)

Department of Physiology, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.

Daniel González-Hedström (D)

Department of Physiology, Faculty of Medicine, Autonomous University of Madrid, 28049 Madrid, Spain.
Pharmactive Biotech Products S.L. Parque Científico de Madrid, Avenida del Doctor Severo Ochoa, 37 Local 4J, 28108 Alcobendas, Spain.

Miriam Granado (M)

Department of Physiology, Faculty of Medicine, Autonomous University of Madrid, 28049 Madrid, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Asunción López-Calderón (A)

Department of Physiology, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH